Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study. Adjei, Araba A , Salavaggione, Oreste E , Mandrekar, Sumithra J ... - - J Thorac Oncol - 2010 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - N0026
Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB 151111 (Alliance) Augert, Arnaud , Zhang, Qing , Bates, Breanna , Cui, Min ... - - J Thorac Oncol - 2017 Manuscript - Secondary Endpoint - Primary Analysis - Sequencing - CALGB-151111
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance) Baggstrom, Maria Q. , Socinski, Mark A. , Wang, Xiaofei F. , Gu, Lin ... - - J Thorac Oncol - 2017 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30607 , CALGB-70701
LACE-Bio: validation of prognostic role of tumour lymphocytic infiltration in resectable non small cell lung cancer Brambilla, E. , Domerg, C. , Lantuejoul, S. , Kratzke, R. ... - - J Thorac Oncol - 2012 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633
A Pooled Exploratory Analysis of the Impact of Tumor Size and KRAS Mutations on Survival Benefit from Adjuvant Platinum-Based Chemotherapy (ACT) in Node Negative (N0) Non-Small Cell Lung Cancer (NSCLC). Cuffe, S. , Graziano, S. , Bourredjem, A. , Pignon, J. P. ... - - J Thorac Oncol - 2011 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633
A Pooled Exploratory Analysis of the Effect of Tumor Size and KRAS Mutations on Survival Benefit from Adjuvant Platinum-Based Chemotherapy in Node Negative Non-Small Cell Lung Cancer Cuffe, Sinead , Bourredjem, Abderrahmane , Graziano, Stephen ... - - J Thorac Oncol - 2012 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633
The impact of occult micrometastases on survival following resection of stage I non-small cell lung cancer: Final analysis of CALGB 9761 D'Cunha, J. , Wang, X. , Groth, S. S. , Vollmer, R. T. ... - IASLC (WCLC) - J Thorac Oncol - 2009 Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-9761
A phase II study of sorafenib in malignant mesothelioma: results of CALGB 30307 Dubey, Sarita , Jänne, Pasi A. , Krug, Lee , Pang, Herbert ... - - J Thorac Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30307
Phase II study of dasatinib in patients with previously treated malignant mesothelioma (cancer and leukemia group B 30601): a brief report Dudek, A. Z. , Pang, H. , Kratzke, R. A. , Otterson, G. A. ... - - J Thorac Oncol - 2012 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30601
A Randomized Phase II Study of Gemcitabine and Carboplatin With or Without Cediranib as First-Line Therapy in Advanced Non-Small Cell Lung Cancer: North Central Cancer Treatment Group Study N0528 Dy, Grace K. , Mandrekar, Sumithra J. , Nelson, Garth D. ... - - J Thorac Oncol - 2013 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0528
NCCTG N0821 (Alliance): A phase II first-line study of pemetrexed, carboplatin and bevacizumab in elderly patients with advanced nonsquamous non-small cell lung cancer with good performance status Dy, Grace K. , Molina, Julian R. , Qi, Yingwei , Ansari, Rafat ... - - J Thorac Oncol - 2014 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0821
CYFRA 21-1 as a prognostic and predictive marker in advanced non-small cell lung cancer in a prospective trial: CALGB 150304 Edelman, Martin J. , Hodgson, Lydia , Rosenblatt, Paula Y. ... - - J Thorac Oncol - 2012 Manuscript - Secondary Endpoint - Primary Analysis - Correl Sci NOS - CALGB-150304
Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304 Edelman, Martin J. , Hodgson, Lydia , Wang, Xiaofei ... - - J Thorac Oncol - 2011 Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-150304 , CALGB-30203
Multi-Trial Evaluation of Progression-Free Survival (PFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Foster, Nathan R. , Renfro, Lindsay A. , Schild, Steven E. ... - - J Thorac Oncol - 2015 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Respiratory - CALGB-30103 , N0424 , NCCTG-932053
Time-to-Treatment-Failure and Related Outcomes among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711) Gajra, Ajeet , Zemla, Tyler J. , Jatoi, Aminah ... - - J Thorac Oncol - 2018 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - A151711 , CALGB-30203 , CALGB-30801 , CALGB-9730
A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104. Govindan, Ramaswamy , Wang, Xiaofei , Baggstrom, Maria Q ... - - J Thorac Oncol - 2009 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30104
Prognostic significance of molecular markers and clinical factors in stage IB non-small cell lung cancer (NSCLC): A laboratory companion study to CALGB 9633 Graziano, S. L. , Gu, L. , Wang, X. , Tatum, A. , Vollmer, R. T. ... - - J Thorac Oncol - 2007 Abstract - Secondary Endpoint - Primary Analysis - Correl Sci NOS - CALGB-159802 , CALGB-9633
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer (NSCLC) treated with adjuvant chemotherapy: Results from IALT, JBR.10 and ANITA Graziano, S. L. , Pignon, J. P. , Vollmer, R. T. , Kratzke, R. A. ... - IASLC (WCLC) - J Thorac Oncol - 2009 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633
Prognostic Significance of Mucin and p53 Expression in Stage IB Non-Small Cell Lung Cancer: A Laboratory Companion Study to CALGB 9633 Graziano, Stephen L. , Gu, Lin , Wang, Xiaofei , Tatum, Arthur H. ... - - J Thorac Oncol - 2010 Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-9633
Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901. Graziano, Stephen L , Herndon, James E , Socinski, Mark A ... - - J Thorac Oncol - 2008 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-39901
A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer Heist, Rebecca S. , Wang, Xiaofei , Hodgson, Lydia ... - - J Thorac Oncol - 2014 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30704
Outcome of advanced NSCLC patients with EGFR exon 19 and 21 mutations treated with erlotinib (E) alone or in combination with carboplatin/paclitaxel (CP) in CALGB 30406 Janne, P. A. , Wang, X. , Socinski, M. A. , Crawford, J. , Gu, L. ... - - J Thorac Oncol - 2011 Abstract - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-30406
Bortezomib, Paclitaxel, and Carboplatin as a First-Line Regimen for Patients with Metastatic Esophageal, Gastric, and Gastroesophageal Cancer: Phase II Results from the North Central Cancer Treatment Group (N044B)1 Jatoi, Aminah , Dakhil, Shaker R. , Foster, Nathan R. , Ma, Cynthia ... - - J Thorac Oncol - 2008 Manuscript - Primary Endpoint - Primary Analysis - GI - N044B
Phase II Study of Preoperative Pemetrexed, Carboplatin, and Radiation Followed by Surgery for Locally Advanced Esophageal Cancer and Gastroesophageal Junction Tumors Jatoi, Aminah , Soori, Gamini , Foster, Nathan R. , Hiatt, Bradley ... - - J Thorac Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - GI - N044E
Phase II Study of Induction Cisplatin and Irinotecan Followed by Concurrent Carboplatin, Etoposide, and Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer, CALGB 30206 Kelley, M. J. , Bogart, J. A. , Hodgson, L. D. , Ansari, R. H. ... - - J Thorac Oncol - 2013 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30206
Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904. Kratzke, Robert A , Wang, Xiaofei , Wong, Long , Kratzke, Marian G ... - - J Thorac Oncol - 2008 Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-159904
A Phase II Study Of Induction Chemotherapy Followed By Thoracic Radiotherapy (TRT) And Erlotinib In Poor-risk Stage III Non-small Cell Lung Cancer (NSCLC): Initial Results Of CALGB 30605 And RTOG 0972 Lilenbaum, R. , Samuels, M. , Kong, F. , Wang, X. , Janne, P. ... - - J Thorac Oncol - 2012 Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30605
A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor risk stage III non-small cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG) Lilenbaum, Rogerio , Samuels, Michael , Wang, Xiaofei ... - - J Thorac Oncol - 2015 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30605
Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial. Liptay, Michael J , D'amico, Thomas A , Nwogu, Chumy , Demmy, Todd L ... - - J Thorac Oncol - 2009 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-140203
Preoperative exercise VO2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238. Loewen, Gregory M , Watson, Dorothy , Kohman, Leslie ... - - J Thorac Oncol - 2007 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-9238
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis. Ma, Xiaoli , Le Teuff, Gwénaël , Lacas, Benjamin , Tsao, Ming Sound ... - - J Thorac Oncol - 2016 Manuscript - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Respiratory - CALGB-150802 , CALGB-9633
A Phase II Study of Dasatinib in Patients with Chemo-sensitive Relapsed Small Cell Lung Cancer (CALGB 30602) Miller, Antonius A. , Pang, Herbert , Hodgson, Lydia ... - - J Thorac Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30602
A Phase II Study of Dasatinib in Patients with Chemo-sensitive Relapsed Small Cell Lung Cancer (CALGB 30602) Miller, Antonius A. , Pang, Herbert , Hodgson, Lydia ... - - J Thorac Oncol - 2009 Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30602
Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002. Miller, Antonius A , Wang, Xiaofei F , Bogart, Jeffrey A ... - - J Thorac Oncol - 2007 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30002
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303). Miller, Antonius A , Wang, Xiaofei F , Gu, Lin , Hoffman, Philip ... - - J Thorac Oncol - 2008 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30303
A phase II study of the VEGFR inhibitor pazopanib (P) in patients with newly diagnosed or relapsed malignant pleural mesothelioma (MPM): an NCCTG study Molina, J. R. , Mandrekar, S. J. , Ziegler, K. L. Allen ... - - J Thorac Oncol - 2009 Abstract - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0623
NCCTG Phase II Trial (N0621) of the SRC inhibitor AZD0530 after 4 cycles of cytoreductive chemotherapy for patients with Extensive Stage Small Cell Lung Cancer (ED-SCLC) Molina, Julian R. , Foster, Nathan R. , Nelson, Garth D. ... - IASLC (WCLC) - J Thorac Oncol - 2009 Abstract - Primary Endpoint - Primary Analysis - Respiratory - N0621
Survival implications of variation in the lymph node (LN) count in ACOSOG Z0030 (Alliance) Osarogiagbon, Raymond U. , Decker, Paul , Ballman, Karla ... - IASLC (WCLC) - J Thorac Oncol - 2015 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030
Phase II Study of the HDAC Inhibitor Romidepsin in Relapsed Small Cell Lung Cancer (CALGB 30304) Otterson, G.A. , Hodgson, L. , Pang, H. ... - - J Thorac Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30304
Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance) Pang, Herbert , Yan, Kang , Kratzke, Robert , Stinchcombe, Thomas ... - IASLC (WCLC) - J Thorac Oncol - 2017 Abstract - No-Endpoint Endpoint - Comprehensive Analysis - Respiratory - CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-8435 , CALGB-8638 , CALGB-8833 , CALGB-8933 , CALGB-9031 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733
LACE-Bio: Cross-validation and Pooled Analyses of the Putative Prognostic/Predictive Biomarkers p27, p16 and cyclin E in IALT, ANITA, JBR10 and CALGB 9633 Pirker, R. , Rousseau, V. , Paris, E. , Tsao, M. S. , Aviel-Ronen, S. ... - - J Thorac Oncol - 2010 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633
Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer Qi, Yingwei , Schild, Steven E. , Mandrekar, Sumithra J. ... - - J Thorac Oncol - 2009 Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - N0424
Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: Cancer and Leukemia group B (CALGB) 30106, a CALGB-stratified phase II trial. Ready, Neal , Jänne, Pasi A , Bogart, Jeffrey , Dipetrillo, Thomas ... - - J Thorac Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30106 , CALGB-150508
Validation of the prognostic and predictive value of class III beta tubulin (TUBB3) for adjuvant chemotherapy (ACT) in completely resected non-small cell lung cancer (R-NSCLC): Results from four randomized trials Reiman, Tony , Seve, Pascal , Veillard, Anne-Sophie ... - IASLC (WCLC) - J Thorac Oncol - 2009 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study. Reungwetwattana, Thanyanan , Molina, Julian R ... - - J Thorac Oncol - 2012 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0323
Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Patients with Unresectable Stage III NSCLC Ross, Helen J. , Kozono, David , Urbanic, James , Williams, Terence ... - IASLC (WCLC) - J Thorac Oncol - 2017 Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Respiratory - AFT-16
A Pooled Analysis of Limited-Stage Small-Cell Lung Cancer Patients Treated with Induction Chemotherapy Followed by Concurrent Platinum-Based Chemotherapy and 70 Gy Daily Radiotherapy: CALGB 30904 Salama, J. K. , Hodgson, L. , Pang, H. , Urbanic, J. J. ... - - J Thorac Oncol - 2013 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30904
Positive Interaction Between Prophylactic Cranial Irradiation And Maintenance Sunitinib For Untreated Extensive Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis Of CALGB 30504 (Alliance) Salama, Joseph K. , Gu, Lin , Wang, Xiaofei , Pang, Herbert H. ... - - J Thorac Oncol - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-30504
PCI Survival Improvement for Extensive Stage SCLC Limited to Patients on Maintenance Systemic Therapy: A Secondary Analysis of CALGB 30504 (Alliance) Salama, Josept K. , Gu, Lin , Wang, Xiaofei , Bogart, Jeffrey ... - IASLC (WCLC) - J Thorac Oncol - 2015 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-30504
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study. Schenk, Erin L , Mandrekar, Sumithra J , Dy, Grace K ... - - J Thorac Oncol - 2020 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0923
Long-term Survival of Patients (pts) Treated with High-dose Radiotherapy(rt) and Concurrent Chemotherapy for Unresectable Non-small Cell Lung Cancer (nsclc) Schild, S. , Hillman, S. , Graham, D. , Vora, S. , Garces, Y. ... - MSTO - J Thorac Oncol - 2012 Abstract - Primary Endpoint - Long-Term-Followup Analysis - Respiratory - NCCTG-N0028
Long-terms results of a trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small cell lung cancer: NCCTG N0028 (Alliance) Schild, Steven E. , Hillman, Shauna L. , Tan, Angelina D. ... - - J Thorac Oncol - 2017 Manuscript - Primary Endpoint - Long-Term-Followup Analysis - Respiratory - NCCTG-N0028
A Pooled Analysis to the Prognosis and Predictive value of EGFR mutation on Survival in Patients with KRAS wild-type Lung Adenocarcinoma. Soria, Jean-Charles , Brambilla, Elisabeth , Le Teuff, Gwénaël ... - - J Thorac Oncol - 2011 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633
Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer Stinchcombe, T. E. , Hodgson, L. , Herndon, J. E. 2nd ... - - J Thorac Oncol - 2009 Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-39801
Risk factors for distant recurrence and brain metastases observed on American College of Surgical Oncology Group trial Z0030: Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) Non- Small Cell Lung Cancer (NSCLC) Stinchcombe, Thomas E. , Decker, Paul A. , Darling, Gail E. ... - IASLC (WCLC) - J Thorac Oncol - 2009 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030
Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B trial 9430 Stinchcombe, Thomas E. , Mauer, Ann M. , Hodgson, Lydia D. ... - - J Thorac Oncol - 2008 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-9430
A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321 Zhao, Yujie , Foster, Nathan R. , Meyers, Jeffrey P. ... - - J Thorac Oncol - 2015 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0321
